Skip to content
-
NASP’s Response Advance Notice of Methodological Changes for Calendar Year (201) for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 201 Call Letter
Mar 04, 2017
The National Association of Specialty Pharmacy (NASP) appreciatesthis opportunity to submit comments on the Centers for... read more
-
NASP’s Comments on HHS’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; Request for Information
Feb 16, 2017
The National Association of Specialty Pharmacy (NASP) represents the entire spectrum of the specialty pharmacy industry... read more
-
Advocacy Documents
Feb 10, 2017
Any Willing Pharmacy (AWP) Changes Are Needed to Improve Beneficiary Access to Specialty Pharmacies Overview of... read more
-
New Report from the Centers for Medicare and Medicaid Services (CMS) Illustrates the Challenges Associated with Direct and Indirect Remuneration (DIR) Fees
Jan 24, 2017
View Press Release The report validates the position of many industry experts that these fees,... read more
-
NASP Issues Letter to CMS
Jun 09, 2016
On March 4, NASP wrote a letter to CMS Deputy Administrator & Director Sean Cavanaugh regarding... read more
-
NASP Comments to CMS on Part B Drug Proposal
Jun 02, 2016
NASP comments on the organization’s concerns over the CMS proposed plan. Download PDF for details. read more
-
NASP Summary of CMS Call Letter
Apr 20, 2016
NASP provides a point-by-point summary of comments made on the 2017 CMS Call Letter and the... read more
-
CMS Issues Final Call Letter
Apr 06, 2015
On April 6, 2015 CMS issued the final payment rates and policy changes to Medicare Advantage... read more
-
CMS Biosimilars Guidance
Apr 02, 2015
Earlier this week the Centers for Medicare & Medicaid Services (CMS) issued four guidance documents detailing... read more
-
NASP Responds to CMS Call Letter
Mar 06, 2015
NASP responded to the CMS 2016 Call Letter with concerns about the impact of narrow network... read more